Wall Street brokerages expect Healthequity Inc (NASDAQ:HQY) to report sales of $73.02 million for the current quarter, Zacks reports. Eight analysts have provided estimates for Healthequity’s earnings. The lowest sales estimate is $71.47 million and the highest is $74.37 million. Healthequity posted sales of $60.44 million during the same quarter last year, which would indicate a positive year over year growth rate of 20.8%. The business is scheduled to issue its next earnings report after the market closes on Wednesday, February 6th.
On average, analysts expect that Healthequity will report full year sales of $284.33 million for the current fiscal year, with estimates ranging from $282.94 million to $285.84 million. For the next financial year, analysts anticipate that the business will report sales of $341.29 million, with estimates ranging from $322.70 million to $349.00 million. Zacks’ sales calculations are an average based on a survey of sell-side analysts that cover Healthequity.
Healthequity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, December 4th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.02. Healthequity had a return on equity of 12.42% and a net margin of 24.52%. The business had revenue of $70.50 million for the quarter, compared to analysts’ expectations of $69.60 million. During the same period last year, the business earned $0.17 EPS. The business’s revenue was up 24.1% on a year-over-year basis.
NASDAQ:HQY traded down $0.91 during trading hours on Thursday, hitting $62.34. 800,170 shares of the company traded hands, compared to its average volume of 1,001,394. Healthequity has a one year low of $47.23 and a one year high of $101.58. The stock has a market cap of $3.95 billion, a PE ratio of 115.44, a price-to-earnings-growth ratio of 2.37 and a beta of 1.78.
In related news, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction dated Tuesday, January 22nd. The stock was sold at an average price of $60.81, for a total value of $243,240.00. Following the sale, the vice president now directly owns 79,200 shares in the company, valued at approximately $4,816,152. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Frank Corvino sold 1,778 shares of the business’s stock in a transaction dated Monday, December 10th. The shares were sold at an average price of $67.78, for a total value of $120,512.84. Following the completion of the sale, the director now owns 5,051 shares in the company, valued at $342,356.78. The disclosure for this sale can be found here. Insiders have sold a total of 15,846 shares of company stock worth $1,058,948 over the last quarter. Company insiders own 4.00% of the company’s stock.
A number of institutional investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Healthequity by 5.9% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,953 shares of the company’s stock valued at $236,000 after acquiring an additional 220 shares during the period. Crossmark Global Holdings Inc. grew its holdings in Healthequity by 6.6% during the 4th quarter. Crossmark Global Holdings Inc. now owns 5,140 shares of the company’s stock valued at $307,000 after buying an additional 320 shares in the last quarter. Retirement Systems of Alabama grew its holdings in Healthequity by 0.3% during the 4th quarter. Retirement Systems of Alabama now owns 133,268 shares of the company’s stock valued at $7,949,000 after buying an additional 372 shares in the last quarter. Legacy Financial Advisors Inc. purchased a new position in Healthequity during the 4th quarter valued at about $28,000. Finally, Arizona State Retirement System grew its holdings in Healthequity by 1.3% during the 4th quarter. Arizona State Retirement System now owns 38,958 shares of the company’s stock valued at $2,324,000 after buying an additional 497 shares in the last quarter. Institutional investors and hedge funds own 92.30% of the company’s stock.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Story: How to execute a trade ex-dividend strategy?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.